Tag: Oxycontin

Oligarch of the Month: The Sacklers

Not so long ago, the Sackler name was stamped across the most rarified perches in Manhattan—in the psychobiology department at Columbia University, at the Metropolitan Museum of Art, and at the Museum of Natural History. Lately, though, we’ve been seeing the Sackler moniker in far less esteemed venues, as a cluster of lawsuits have uncovered […]

Read More

We Didn’t Stand a Chance Against Opioids

My ancestors had no written language, so they told their stories to the trees. Ten thousand years after the Tlingit people settled Alaska’s southeastern archipelago, these islands remain stippled with monuments to their myths: totem poles, carved from massive logs of cedar and adorned with images of animals and spirits, rise up from the damp […]

Read More

Opioid Settlement Needs to Transform the Pharmaceutical Industry

Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached a tentative settlement with some of the plaintiffs last week. In the deal, Perdue would transform itself through the bankruptcy process from a typical, profit-chasing drugmaker into a “public […]

Read More

The Case for a Public Option for the Drug Industry

Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached a tentative settlement with some of the plaintiffs last week. In the deal, Purdue would transform itself through the bankruptcy process from a typical, profit-chasing drugmaker into a “public […]

Read More

Oligarch of the Month: Laurence Doud III

In 2016, Laurence Doud III had a seven-figure salary, an honorary degree from the Albany College of Pharmacy, and a beach home in Florida. As Rochester Drug Cooperative’s CEO, he’d handed out lavish bonuses and increased revenue a hundredfold. When he retired the following year, the company lauded his vision. Then, this past April, appearing […]

Read More